# Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers

> **NCT01796899** · PHASE1 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 25 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **OTHER:** Brivaracetam 10 mg oral tablet
- **OTHER:** Brivaracetam 50 mg oral tablet
- **OTHER:** Brivaracetam 75 mg oral tablet
- **OTHER:** Brivaracetam 100 mg oral tablet
- **OTHER:** 10 mL of Brivaracetam intravenous bolus injection (10 mg/mL)

## Key facts

- **NCT ID:** NCT01796899
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01796899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01796899, "Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01796899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*